"Although we expected this ruling, it is gratifying to see another Court validate our position that Kurin Lock does not infringe Magnolia patents, as they had claimed. This ruling affirms the strength ...

SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent ...

SAN DIEGO--(BUSINESS WIRE)--Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that Oishei Children’s Hospital, a member of Kaleida ...

Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...

SEATTLE, Dec. 7, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for ...

Blood culture is the most widely used diagnostic tool for the detection of bacteremia and fungemia. It is the most important way to diagnose the etiology of bloodstream infections and has major ...

The success of blood cultures is dependent on the collection of uncontaminated specimens, culture of a large volume of blood, and inoculation of multiple media types to maximize the recovery of most ...

SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...

The FDA sent a letter to healthcare providers July 10 regarding the shortage, and the CDC released updated conservation strategies in a July 22 statement. The FDA estimates the shortage will continue ...

FRANKLIN LAKES, N.J., Oct. 18, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today ...